Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults With B-lymphocyte Antigen CD20 (CD20) Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplantation (SOT)

NCT00066469 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00066469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00066469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults With B-lymphocyte Antigen CD20 (CD20) Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplantation (SOT)
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2013
Enrollment
55 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoproliferative disorder